The Symposium

About the Symposium

Drug discovery identifies potential new therapeutic entities using computational, experimental, translational, and clinical models. Despite advances in biotechnology and understanding of biological systems, drug discovery is still lengthy, costly, and difficult with a high attrition rate of new therapeutic discovery. A complete drug discovery business process typically involves four phases: Early Drug Discovery, Pre-Clinical Phase, Clinical Phases, and Regulatory Approval.

The First Cannabinoid Translational Science Symposium aims to strengthen connections between all the actors of the drug discovery process in the cannabinoid field. Experts who design the new chemical entities will be brought into contact with experts who validate the therapeutic potential of such molecules at the pre-clinical or clinical levels and specialists in regulatory affairs who deal with organization adherence to regulatory compliance.

To favor productive dialogs between all stakeholders, at the end of each scientific session, all speakers will participate in chaired panel discussions to foster and translate cannabinoid science into practice.

Why a cannabinoid translational science symposium?

Cannabinoids are molecules acting on a tightly regulated and complex system (the endocannabinoid system), which represent a promising therapeutic strategy for a plethora of treatments. Despite the enormous progress and knowledge of devoted research and technological advances to date achieved, the exploitation of the cannabinoid therapeutical potential is not at its maximum yet. Translating a scientific discovery from the laboratory to human application involves a series of challenges. We do believe that fostering communication between the key stakeholders is a mandatory action needed to succeed in such a goal.

The Cannabinoid Translational Science symposium aims at gathering a diverse range of speakers and discussion leaders from different institutions, organizations, and industries worldwide and it is mainly focused on strengthening a bridge between companies and academics working in the cannabinoid field.

Chairs:

Alessia Ligresti and Marialessandra Contino

Scientific committee:

Carmen Abate (UniBA), Angela Stefanachi (UniBa), Giuseppe Mangiatordi (CNR), Fabiana Piscitelli (CNR)

Editions and Promotions

The first edition of the Cannabinoid Translational Science Symposium will be held remotely
on February 2025, Monday 10^th, Monday 17^th, and Monday 24^th.

Each day a different theme will be deepened:

• Neuroinflammation
• Oncology and Pain
• Trials for Therapeutic and Drug Development Purposes